Acutus Medical Alpha and Beta Analysis
| AFIBDelisted Stock | USD 0.73 0.03 3.95% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Acutus Medical. It also helps investors analyze the systematic and unsystematic risks associated with investing in Acutus Medical over a specified time horizon. Remember, high Acutus Medical's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Acutus Medical's market risk premium analysis include:
Beta 0.0 | Alpha 0.0 | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Acutus |
Acutus Medical Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Acutus Medical market risk premium is the additional return an investor will receive from holding Acutus Medical long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Acutus Medical. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Acutus Medical's performance over market.| α | 0.00 | β | 0.00 |
Acutus Medical Fundamentals Vs Peers
Comparing Acutus Medical's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Acutus Medical's direct or indirect competition across all of the common fundamentals between Acutus Medical and the related equities. This way, we can detect undervalued stocks with similar characteristics as Acutus Medical or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Acutus Medical's fundamental indicators could also be used in its relative valuation, which is a method of valuing Acutus Medical by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Acutus Medical to competition |
| Fundamentals | Acutus Medical | Peer Average |
| Return On Equity | -0.32 | -0.31 |
| Return On Asset | -0.14 | -0.14 |
| Operating Margin | (2.89) % | (5.51) % |
| Current Valuation | 18.75 M | 16.62 B |
| Shares Outstanding | 29.72 M | 571.82 M |
| Shares Owned By Insiders | 3.15 % | 10.09 % |
| Shares Owned By Institutions | 23.50 % | 39.21 % |
Acutus Medical Opportunities
Acutus Medical Return and Market Media
The Stock did not receive any noticable media coverage during the period. Price Growth (%) |
| Timeline |
About Acutus Medical Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Acutus or other delisted stocks. Alpha measures the amount that position in Acutus Medical has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Acutus Medical Upcoming Company Events
As portrayed in its financial statements, the presentation of Acutus Medical's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Acutus Medical's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Acutus Medical's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Acutus Medical. Please utilize our Beneish M Score to check the likelihood of Acutus Medical's management manipulating its earnings.
| 21st of March 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 30th of September 2023 Last Quarter Report | View |
Build Portfolio with Acutus Medical
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Consideration for investing in Acutus Stock
If you are still planning to invest in Acutus Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Acutus Medical's history and understand the potential risks before investing.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |